BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15849886)

  • 1. Organ preservation: III.
    Hanna EY
    Curr Oncol Rep; 2001 Jan; 3(1):45. PubMed ID: 15849886
    [No Abstract]   [Full Text] [Related]  

  • 2. Organ preservation: II.
    Hanna EY
    Curr Oncol Rep; 2001 Jan; 3(1):44. PubMed ID: 15849884
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional p53 status as a biomarker for chemotherapy response in oral-cavity cancer.
    Mroz EA; Rocco JW
    J Clin Oncol; 2010 Feb; 28(5):715-7. PubMed ID: 20048171
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neoadjuvant radiochemotherapy for squamous cell carcinoma of the oral cavity].
    Bootz F
    HNO; 2008 Feb; 56(2):183-4. PubMed ID: 18231725
    [No Abstract]   [Full Text] [Related]  

  • 5. [5-year survival rate of patients with squamous cell cancers of the mouth; a retrospective comparative study].
    Höltje WJ; Schwipper V; Klose G; Machner T
    Fortschr Kiefer Gesichtschir; 1992; 37():26-9. PubMed ID: 1639303
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical studies of preoperative tumor reductive chemotherapy with PPV regimen in the treatment of oral squamous cell carcinoma].
    Jin Y; Shen Y; Ma G
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1995 May; 30(3):166-8. PubMed ID: 7489653
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of a surgical method in combined and complex treatment of patients with squamous cell oral and oropharyngeal cancer].
    Vikhlianov IV; Shoĭket IaN; Lazarev AF
    Khirurgiia (Mosk); 2007; (1):55-8. PubMed ID: 17426691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis on prognostic impact of adjuvant chemotherapy in the patients with advanced and resectable oral squamous cell carcinoma.
    Kurita H; Koike T; Miyazawa H; Uehara S; Kobayashi H; Kurashina K
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):915-21. PubMed ID: 16835480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of modern reconstruction procedures on radicality and survival time in mouth cancer].
    Mühling J; Reuther J; Weber W; Ordung R; Brillinger A
    Fortschr Kiefer Gesichtschir; 1992; 37():86-8. PubMed ID: 1639326
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma.
    Nakazawa M; Ohnishi T; Ohmae M; Chisoku H; Yui S; Iwai S; Sumi T; Fukuda Y; Kishino M; Yura Y
    Int J Clin Pharmacol Res; 2005; 25(3):115-22. PubMed ID: 16366419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of surgical margin status in oral squamous cell carcinoma: a preliminary report.
    Yahalom R; Dobriyan A; Vered M; Talmi YP; Teicher S; Bedrin L
    J Surg Oncol; 2008 Dec; 98(8):572-8. PubMed ID: 18449877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative radiochemotherapy in the treatment of advanced oral cancer: outcome of 276 patients.
    Klug C; Berzaczy D; Voracek M; Nell C; Ploder O; Millesi W; Ewers R
    J Craniomaxillofac Surg; 2009 Sep; 37(6):344-7. PubMed ID: 19525119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological markers and prognosis in recurrent oral cancer after salvage surgery.
    Agra IM; Carvalho AL; Pinto CA; Martins EP; Filho JG; Soares FA; Kowalski LP
    Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):743-9. PubMed ID: 18645125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Statistical results in patients with squamous cell cancer of the mouth, 1981-1990 patient sample].
    Weber W; Reuther J; Mühling J; Ordung R; Michel C
    Fortschr Kiefer Gesichtschir; 1992; 37():33-6. PubMed ID: 1639306
    [No Abstract]   [Full Text] [Related]  

  • 15. Preoperative paclitaxel/carboplatin radiochemotherapy for stage III/IV resectable oral and oropharyngeal cancer: seven-year follow-up of a phase II trial.
    Eckardt A; Sinikovic B; Hofele C; Bremer M; Reuter C
    Oncology; 2007; 73(3-4):198-203. PubMed ID: 18424883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival in locally advanced oral cavity cancer: an analysis of patients treated with neoadjuvant cisplatin-based chemotherapy followed by surgery.
    Ruggeri EM; Carlini P; Pollera CF; De Marco S; Ruscito P; Pinnarò P; Nardi M; Giannarelli D; Cognetti F
    Head Neck; 2005 Jun; 27(6):452-8. PubMed ID: 15880411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying risk factors for postoperative cardiovascular and respiratory complications after major oral cancer surgery.
    Dillon JK; Liu SY; Patel CM; Schmidt BL
    Head Neck; 2011 Jan; 33(1):112-6. PubMed ID: 20578073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The importance of the surgical treatment method in cancer of the oral mucosa with the primary tumor 4 cm in size and larger].
    Liubaev VL; Brzhezovskiĭ VZh; Amparaliev NM
    Stomatologiia (Mosk); 1992; (1):56-8. PubMed ID: 1440680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ preservation in head and neck cancer: are there reliable molecular predictors?
    Hanna EY
    Curr Oncol Rep; 2001 Jan; 3(1):43-4. PubMed ID: 11123868
    [No Abstract]   [Full Text] [Related]  

  • 20. Results of multidisciplinary therapy of squamous cell carcinoma of the buccal mucosa at Srinagarind Hospital, Thailand.
    Jenwitheesuk K; Surakunprapha P; Chowchuen B; Tangvoraphongchai V; Pesee M; Krusun S; Supaadirek C
    J Med Assoc Thai; 2010 Nov; 93(11):1262-7. PubMed ID: 21114204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.